- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/41 - Vertebrate antigens
Patent holdings for IPC class A61K 40/41
Total number of patents in this class: 325
10-year publication summary
|
3
|
7
|
4
|
19
|
14
|
27
|
21
|
11
|
81
|
84
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4435 |
11 |
| The Regents of the University of California | 20868 |
8 |
| Washington University | 1761 |
7 |
| Sonoma Biotherapeutics, Inc. | 38 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6707 |
5 |
| Cellectis | 415 |
5 |
| Tr1x, Inc. | 16 |
5 |
| Memorial Sloan-Kettering Cancer Center | 2058 |
4 |
| The Regents of the University of Colorado, a body corporate | 2841 |
4 |
| Regents of the University of Minnesota | 2801 |
4 |
| Trustees of Dartmouth College | 1120 |
4 |
| Allogene Therapeutics, Inc. | 167 |
4 |
| Junten Bio Co., Ltd. | 17 |
4 |
| Quell Therapeutics Limited | 57 |
4 |
| Angeles Therapeutics, Inc. | 21 |
4 |
| The Board of Trustees of the University of Illinois | 2755 |
3 |
| Baylor College of Medicine | 1013 |
3 |
| Benaroya Research Institute at Virginia Mason | 42 |
3 |
| Board of Regents of the University of Nebraska | 795 |
3 |
| Juno Therapeutics, Inc. | 503 |
3 |
| Other owners | 231 |